PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25742310-7	2015	DTIC+DM-1 treatment induced the recovery of anemia arising from melanoma and immunomodulation.	Dacarbazine	0-4	immunoglobulin heavy diversity 1-7	Homo sapiens	5-9	
23359272-4	2013	The objective of this study was to evaluate the signaling pathways involved in melanoma cell death after treatment with DM-1 compared to the standard agent for melanoma treatment, DTIC.	Dacarbazine	180-184	immunoglobulin heavy diversity 1-7	Homo sapiens	120-124	
23359272-13	2013	DM-1 antitumor therapy in vivo showed tumor burden decrease with DM-1 monotherapy or in combination with DTIC, besides survival rate increase.	Dacarbazine	105-109	immunoglobulin heavy diversity 1-7	Homo sapiens	0-4